Recent offerings have pushed Hong Kong stock exchange back to the top of the global IPO rankings. Photo: AP

Chinese heart valve replacement maker Venus Medtech plans to raise up to US$381 million in Hong Kong IPO

  • Hangzhou-based company expects to price its offering in a range of HK$29 to HK$33 a share
  • IPO latest sign of confidence returning to Hong Kong’s financial markets
Topic |   IPO
Recent offerings have pushed Hong Kong stock exchange back to the top of the global IPO rankings. Photo: AP
READ FULL ARTICLE